We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Williams Companies
WMB
$85.8B
| $40M | 0.09% |
1,350,852
+187,001
| +16% | +$5.41M |
|
227
Western Digital
WDC
$159B
| $39.9M | 0.09% |
638,828
+13,710
| +2% | +$788K |
|
228
Boston Properties
BXP
$11.6B
| $39.5M | 0.09% |
298,374
-5,259
| -2% | -$697K |
|
229
Keurig Dr Pepper
KDP
$42.8B
| $39.1M | 0.09% |
399,323
+21,450
| +6% | +$2M |
|
230
Public Service Enterprise Group
PEG
$38.7B
| $39.1M | 0.09% |
880,938
-19,598
| -2% | -$865K |
|
231
HCA Healthcare
HCA
$90.6B
| $39.1M | 0.09% |
438,826
+13,914
| +3% | +$1.16M |
|
232
Trane Technologies
TT
$98.8B
| $38.9M | 0.09% |
478,705
+15,253
| +3% | +$1.21M |
|
233
Stanley Black & Decker
SWK
$14.5B
| $38.7M | 0.09% |
291,483
+9,422
| +3% | +$1.18M |
|
234
Ameriprise Financial
AMP
$47.8B
| $38.5M | 0.09% |
296,885
+5,069
| +2% | +$627K |
|
235
Devon Energy
DVN
$51.3B
| $38.5M | 0.09% |
922,210
+27,218
| +3% | +$1.2M |
|
|
BCR
236
DELISTED
CR Bard Inc.
BCR
| $38.4M | 0.09% |
154,470
+3,793
| +3% | +$914K |
|
237
Newell Brands
NWL
$2.21B
| $38.2M | 0.09% |
809,439
+7,306
| +0.9% | +$347K |
|
238
Aptiv
APTV
$12.3B
| $38M | 0.09% |
472,347
+11,438
| +2% | +$859K |
|
239
Edwards Lifesciences
EW
$49.4B
| $37.8M | 0.09% |
1,204,641
+14,418
| +1% | +$451K |
|
240
United Airlines
UAL
$38.8B
| $37.7M | 0.09% |
533,473
+16,113
| +3% | +$1.16M |
|
241
Yum! Brands
YUM
$41.9B
| $37.6M | 0.09% |
587,719
+6,619
| +1% | +$431K |
|
242
Tyson Foods
TSN
$21.5B
| $37.3M | 0.09% |
604,208
+14,835
| +3% | +$935K |
|
243
WEC Energy
WEC
$36.3B
| $37.3M | 0.09% |
614,979
+15,088
| +3% | +$889K |
|
|
K
244
DELISTED
Kellanova
K
| $37M | 0.09% |
542,360
+8,529
| +2% | +$589K |
|
245
International Paper
IP
$22.6B
| $36.7M | 0.09% |
762,703
+16,385
| +2% | +$821K |
|
246
Moody's
MCO
$83.7B
| $36.4M | 0.09% |
325,088
+13,433
| +4% | +$1.44M |
|
247
American Airlines Group
AAL
$9.82B
| $36.1M | 0.08% |
853,729
+20,912
| +3% | +$946K |
|
248
Conagra Brands
CAG
$7.42B
| $35.9M | 0.08% |
890,017
+7,338
| +0.8% | +$293K |
|
249
Digital Realty Trust
DLR
$69.6B
| $35.8M | 0.08% |
336,405
+15,713
| +5% | +$1.65M |
|
250
State Street SPDR S&P 500 ETF Trust
SPY
$771B
| $35.6M | 0.08% |
150,889
+46,067
| +44% | +$10.7M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.